Home > Balance Sheet > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Total Current Liabilities

    Back to Balance Sheet
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Current Liabilities ₹3,210 Cr₹3,019 Cr₹2,965 Cr₹3,408 Cr₹2,920 Cr

What is the latest Total Current Liabilities ratio of EMCURE PHARMACEUTICALS ?

The latest Total Current Liabilities ratio of EMCURE PHARMACEUTICALS is ₹3,210 Cr based on Mar2024 Consolidated results.
Year Total Current Liabilities
Mar2024₹3,210 Cr
Mar2023₹3,019 Cr
Mar2022₹2,965 Cr
Mar2021₹3,408 Cr
Mar2020₹2,920 Cr

How is Total Current Liabilities of EMCURE PHARMACEUTICALS Trending?

Years Total Current Liabilities % Change
Mar2024 ₹3,210 Cr
6.34
Mar2023 ₹3,019 Cr
1.83
Mar2022 ₹2,965 Cr
-13.01
Mar2021 ₹3,408 Cr
16.72
Mar2020 ₹2,920 Cr -

Compare Total Current Liabilities of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹20,743.6 Cr 20.9% 18.2% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,136.0 Cr 6% 4% 9.9% Stock Analytics
DIVIS LABORATORIES ₹149,680.0 Cr 4.7% 0.3% 52.4% Stock Analytics
CIPLA ₹122,394.0 Cr 7% 3.7% 7.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,159.0 Cr 4.1% 6.4% 25% Stock Analytics
DR REDDYS LABORATORIES ₹97,105.6 Cr 6.3% 5% -4.7% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

20.9%

18.2%

NA
SENSEX

5.8%

6.1%

4.7%


You may also like the below Video Courses